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ATP-dependent substrate transport by the ABC
transporter MsbA is proton-coupled
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ATP-binding cassette transporters mediate the transbilayer movement of a vast number of
substrates in or out of cells in organisms ranging from bacteria to humans. Current
alternating access models for ABC exporters including the multidrug and Lipid A transporter
MsbA from Escherichia coli suggest a role for nucleotide as the fundamental source of free
energy. These models involve cycling between conformations with inward- and outward-
facing substrate-binding sites in response to engagement and hydrolysis of ATP at the
nucleotide-binding domains. Here we report that MsbA also utilizes another major energy
currency in the cell by coupling substrate transport to a transmembrane electrochemical
proton gradient. The dependence of ATP-dependent transport on proton coupling, and the
stimulation of MsbA-ATPase by the chemical proton gradient highlight the functional
integration of both forms of metabolic energy. These ﬁndings introduce ion coupling as a new
parameter in the mechanism of this homodimeric ABC transporter.
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A
TP-binding cassette (ABC) multidrug exporters are
embedded in the plasma membrane and actively extrude
cytotoxic drugs from the cell1. They play a critical role in
the failure of pharmacological treatment of microbial diseases and
cancers, affect drug pharmacokinetics in mammals and are a
prime target for clinical research2,3. Some of these transporters,
including the mammalian multidrug resistance P-glycoprotein
ABCB1 and its bacterial homologues MsbA and LmrA, transport
lipids and chemotherapeutic drugs from the inner leaﬂet of the
plasma membrane to the outer leaﬂet and extracellular
environment4–8.
ABC exporters are thought to utilize the free energy from
ATP-binding and hydrolysis at two nucleotide-binding domains
(NBDs) to transport substrates via a translocation pathway that is
formed by two membrane domains (MDs)9,10. In ABCB1, these
four domains are fused on a single polypeptide, whereas in
bacterial MsbA and LmrA, an MD is fused to an NBD in a
half-transporter that homodimerizes to form the full transporter.
Current structural and biochemical data support an ‘alternating
access’ model in which the substrate-binding sites in the
MDs are exposed to either side of the membrane as the
transporter alternates between inward-facing and outward-
facing conformational states11–13. The transition from the
inward-facing conformation to the outward-facing conformation
is governed by ATP-binding-associated NBD dimerization, often
referred to as ‘the power stroke’, after which ATP hydrolysis and
ADP-and-Pi-release-dependent NBD dissociation resets the
transporter to the inward-facing conformation. However, many
important details of this mechanism remain to be elucidated.
MsbA transports cytotoxic agents and the Lipid A anchor of
lipopolysaccharides14–17, and is an essential transporter in many
Gram-negative bacteria18–20. Here we show for Escherichia coli
MsbA that ATP binding and hydrolysis are insufﬁcient to drive
drug transport in the absence of an electrochemical proton
gradient. We conclude that proton coupling is essential in the
nucleotide-dependent power stroke in MsbA.
Results
Studies in intact cells. Energy coupling by MsbA was ﬁrst studied
in ATP-depleted Lactococcus lactis cells with a very low internal
ATP concentration of B7 mM (ref. 21) that were preloaded with
2 mM ethidium by reversed transport by MsbA15,16 (Fig. 1). After
a steady state was reached, the addition of glucose raised the
intracellular ATP concentration toB9mM (ref. 21), and initiated
a signiﬁcant ethidium efﬂux activity by wild-type MsbA
(MsbA-WT) compared with the non-expressing control
(Fig. 1c,d). Surprisingly, ethidium efﬂux was also observed for
cells containing MsbA-MD (Fig. 1c,d), a truncated form of
MsbA-WT that lacks the NBD and that is expressed in a similar
orientation and at a moderately elevated level (117%) in the
plasma membrane compared with MsbA-WT (Fig. 1a,b).
To investigate the possibility that transport by MsbA-MD in
these cells is dependent on an electrochemical proton gradient,
also referred to as the protonmotive force (Dp, interior positive
and acidic), or one of its components, the transmembrane pH
gradient (DpH) and electrical membrane potential difference
(Dc), measurements of ethidium efﬂux by MsbA-MD were
repeated in cells in which the magnitude and composition of the
Dp (¼DcZDpH in which Z is approximately equal to 58mV
at 20 C) was manipulated with the ionophores nigericin
and valinomycin22. The results show that ethidium efﬂux by
MsbA-MD was completely inhibited in the presence of the Dc
only. In contrast, signiﬁcant efﬂux was observed in the presence
of the DpH only (Fig. 1e). The results for MsbA-WT (Fig. 1f)
showed similarities with those for MsbA-MD, and both were
clearly different from non-expressing control cells for which no
ethidium efﬂux was observed (Fig. 1g). Previous studies in cells
highlighted the dependency of ethidium efﬂux by MsbA-WT on
ATP binding and hydrolysis; the efﬂux activity is strongly
inhibited by impairment of the MsbA-ATPase activity down to
4–6% of WT activity through the deletion of the Walker A lysine
residue at position 382 (DK382 mutation)16,23. Indeed, although
the expression level of MsbA-DK382 was only slightly below that
of MsbA-WT (77%; Fig. 1a), the ethidium transport activity of the
mutant was strongly inhibited (Fig. 1c,d). Taken together,
these ﬁndings suggest that MsbA-mediated ethidium efﬂux is
dependent on both the electrochemical proton gradient and ATP
hydrolysis.
Proton-coupled substrate transport in proteoliposomes. To
investigate the dependence of transport activity of MsbA on the
electrochemical proton gradient in the absence of nucleotides and
other components, MsbA-WT, MsbA-MD, MsbA-DK382 and the
transport-inactive triple mutant MsbA-DED (D41N in trans-
membrane helix (TMH) 1, E149Q in TMH 3 and D252N in
TMH 5) were afﬁnity-puriﬁed and reconstituted in proteolipo-
somes prepared from E. coli phospholipids7,24. Unlike whole
cells, spheroplasts and plasma membrane vesicles, these
proteoliposomes are devoid of cytoplasmic constituents and
alternative primary-active and secondary-active transporters,
allowing studies on the transport and energetics of puriﬁed
MsbA proteins in the absence of energy-transducing transport
processes. The MsbA proteins incorporated equally well in
proteoliposomes and were present in an inside-out orientation
(Fig. 2a,b). Puriﬁed MsbA-WT and MsbA-MD samples used for
the reconstitution experiments were examined by LC-MS/MS
mass spectrometry. This analysis conﬁrmed the lack of the native
NBD in the MsbA-MD protein (Fig. 2c). The Mascot database
was also searched against the UniProt L. lactis subsp. lactis
database, which demonstrated insigniﬁcant levels of contami-
nating membrane transporters and ABC NBDs (Supplementary
Data 1), below 0.01% for MsbA-WT and 0.7% for MsbA-MD
when the exponentially modiﬁed protein abundance index was
used as a measure for the protein abundance25.
To study the functionality of the MsbA proteins in the
proteoliposomes, a DpH (interior acidic) was generated by pH
jump (Fig. 3). In this method, proteoliposomes prepared in buffer
pH 6.8 were diluted in buffer pH 8.0, imposing a difference
between the interior pH and external pH by pH jump (pHin
6.8/pHout 8.0). This pH difference was sustained by dissociation
of NH4þ in the lumen of proteoliposomes and the outward
diffusion of NH3. The Dc (interior positive) was imposed by
diffusion of SCN from the lumen down an outwardly directed
chemical gradient ([SCN ]in/[SCN ]out¼ 100mM versus
1mM). No changes in ethidium ﬂuorescence were observed
upon imposition of Dc and/or DpH in liposomes lacking MsbA
proteins (Fig. 4a) or containing inactive MsbA-DED (Fig. 4b).
These results are consistent with the mass spectrometry data
showing the absence of contaminating membrane transporters in
our protein preparations (Fig. 2c and Supplementary Data 1).
However, for both MsbA-WT (Fig. 4c) and MsbA-MD (Fig. 4d),
ethidium transport in the proteoliposomes with the imposed DpH
(interior acidic) was signiﬁcantly higher, more than ﬁvefold for
MsbA-WT compared with the equilibration level in the
no-gradient controls (pHin 6.8/pHout 6.8 and pHin 8.0/pHout 8.0).
These results point to concentrative DpH-dependent accumulation
of ethidium. In contrast, uptake of ethidium by MsbA-WT and
MsbA-MD was not stimulated in the presence of a reversed DpH
(DpHREV, interior alkaline), which was imposed by the passive
diffusion of acetic acid from the lumen of the proteoliposomes
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(Figs 3 and 4c,d). Upon the imposition of the Dc plus DpH
(Dp, interior positive and acidic), ethidium transport was above
control but was reduced compared with the activity obtained in
the presence of the DpH only (Fig. 4c,d). As these results
suggested that the imposed Dc (interior positive) was inhibitory
for ethidium transport in proteoliposomes, the effect of reversed
Dc (DcREV, inside negative) was tested. The DcREV was imposed
in the proteoliposomes by the electrogenic downhill diffusion
of Kþ from the lumen to the external buffer by valinomycin
(added at 10 nmol (mg of protein) 1; Fig. 3), and was found
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Figure 1 | Ethidium efﬂux in intact cells. (a) Immunoblot probed with anti-polyhistidine tag antibody (left) shows that MsbA-MD and MsbA-DK382 are
expressed in the plasma membrane of L. lactis (5mg total membrane protein per lane) at 117% and 77% of MsbA-WT, respectively, and that these proteins
are absent in control cells (Ctrl). The migration of molecular mass markers is indicated. Histogram (right) shows MsbA signal intensities. (b) Availability of
the cytosolic NH2-terminal His-tag in MsbA-WT and MsbA-MD to cleavage by proteinase K (þ PK) at the external side of right-side-out (RSO) or
inside-out (ISO) membrane vesicles (3mg protein per lane). Incubation without the protease (-PK) served as control. Uncleaved His-tag was detected on
immunoblot (left). Signal intensities are shown in the histogram (right). (c) Efﬂux of monovalent cationic ethidium was initiated by the addition of 20mM
glucose (Glc) as a source of metabolic energy to ATP-depleted cells that were preloaded with 2 mM of the dye. Efﬂux was observed for MsbA-WT but not
for non-expressing control or MsbA-DK382, which exhibits a strongly reduced ATPase activity due to the absence of the catalytic Walker A lysine residue.
Remarkably, ethidium efﬂux was also observed for a truncated form of MsbA-WT that lacks the NBD (MsbA-MD). (d) Histogram shows signiﬁcance of
ﬂuorescence levels in (c) at t¼400 s. (e–g) Ethidium efﬂux from cells containing MsbA-MD (e), MsbA-WT (f) or no MsbA proteins (g) to which
ionophores nigericin (Dc only, interior negative), valinomycin (DpH only, interior alkaline) or both (no Dp) were added at concentrations of 1.0 and 0.1 mM,
respectively, 3min prior to the addition of the glucose. Data represent observations in 3 or more independent experiments with independently prepared
batches of cells. Values in histograms are expressed as mean±s.e.m. (one-way analysis of variance; *Po0.05; **Po0.01; ***Po0.001; ****Po0.0001).
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to stimulate ethidium transport in the proteoliposomes,
also when combined with the DpH (interior acidic), yielding
DpDcREV ¼ DcREVZDpH (Fig. 4e). No increase in ethidium
ﬂuorescence was observed under these conditions in liposomes
lacking MsbA proteins (Fig. 4f). When taken together in the
physiological context of the cell (Dp, interior negative and
alkaline), these ﬁndings indicate that the DpH (interior alkaline)
supports ethidium efﬂux by MsbA-WT and MsbA-MD, whereas
the Dc (interior negative) inhibits this activity.
Proton-coupled substrate transport by MsbA proteins was
also observed for the neutral antibiotic chloramphenicol20.
The 100-fold dilution of (proteo)liposomes in dilution buffer
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Figure 2 | Puriﬁed MsbA proteins in proteoliposomes. (a) Immunoblot of proteoliposomes prepared from E. coli phospholipids (5 mg protein per lane)
(left) demonstrates the equal incorporation of puriﬁed transport-inactive triple mutant MsbA-DED, MsbA-MD, MsbA-DK382 and MsbA-WT, and the
absence of membrane proteins in empty control liposomes (Ctrl). Histogram (right) shows MsbA signal intensities. (b) Availability of the His-tag in
MsbA-WT (3mg protein per lane) to cleavage by Proteinase K (PK) at the external side of proteoliposomes (left) and corresponding signal intensities
(right) demonstrate the inside-out orientation of the reconstituted protein. (c) Puriﬁed MsbA-WT and MsbA-MD preparations for reconstitution
experiments were subjected to LC–MS/MS mass spectrometry. Mascot protein coverage maps for MsbA-WT and MsbA-MD are shown. The sequence
stretches in red correlate to the peptides that were identiﬁed in these experiments. The MsbA-MD sequence shows a lack of peptides identiﬁed along the
NBD stretch of full-length MsbA-WT. Data represent observations in three or more independent experiments with independently prepared batches of
proteoliposomes. Values in histograms are expressed as mean±s.e.m. (a, one-way analysis of variance; b, unpaired student-t test; ***Po0.001).
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containing 2 mM [3H]-chloramphenicol initiated the time-
dependent accumulation of chloramphenicol in proteoliposomes
containing reconstituted MsbA-WT or MsbA-MD in the
presence of the imposed DpH (interior acidic), but not in the
absence of the DpH or in empty liposomes without MsbA
proteins (Fig. 5a,b). Thus, the proton dependence of
MsbA-mediated transport is observed for two different
substrates, chloramphenicol and ethidium, with different charge
and hydrophobicity. Using (proteo)liposomes loaded with the pH
indicator 20,70-bis-(2-carboxyethyl)-5-(and-6)-carboxyﬂuorescein
(BCECF), the ﬂuorescence emission of which increases at
alkaline pH, chloramphenicol uptake by MsbA-WT in the
proteoliposomes was found to be associated with proton efﬂux
down its chemical gradient (pHin 6.8/pHout 8.0; Fig. 5c). This
result is consistent with the no-gradient control experiments
in Fig. 4c in which ethidium transport by MsbA-WT in
proteoliposomes was not initiated by changes in local pH in the
lumen or external buffer (pHin 6.8/pHout 6.8 and pHin 8.0/pHout
8.0) but required the imposition of a transmembrane DpH
(interior acidic).
Proton coupling is functionally linked to ATP hydrolysis. In
view of the ﬁnding that ethidium transport by MsbA is dependent
on ATP hydrolysis (Fig. 1c) and components of the Dp (Figs 1f
and 4c,e), the relationship between these two forms of metabolic
energy was further studied in proteoliposomes. For this purpose,
ethidium uptake in MsbA-WT-containing proteoliposomes
was measured in the absence or presence of the imposed DpH
(inside acidic; pHin 6.8/pHout 8.0) in buffer containing 2.5mM
Mg-ATP or non-hydrolysable nucleotide analogue AMP-PNP.
Remarkably, the ATP did not initiate ethidium accumulation
in the absence of the DpH, nor did the nucleotide enhance
DpH-dependent transport (Fig. 6a). However, the DpH-
dependent accumulation of ethidium was strongly inhibited by
the replacement of ATP by the non-hydrolysable analogue
AMP-PNP (Fig. 6a). These data demonstrate the importance
of ATP hydrolysis by MsbA-WT in experiments where ATP is
co-applied with the imposed DpH. In agreement with this,
measurements of the MsbA-ATPase activity in proteoliposomes
showed that imposition of the DpH (pHin 6.8/pHout 8.0) stimu-
lated the ATPase activity of MsbA-WT compared with controls
in which the DpH was dissipated through the addition of niger-
icin (pHin becomes equal to pHout¼ 8.0; Fig. 6b,c) or in which the
DpH was not imposed (pHin/pHout set at 8.0/8.0; Fig. 6d). In these
experiments, the local pH near the MsbA-NBD at the external
side of the membrane remained constant. These data suggest that
the conformational changes in MsbA-WT associated with ethi-
dium transport can occur in the absence of ATP in a reaction
driven by a DpH and DcREV. However, when ion gradients are
imposed in the presence of ATP, proton coupling becomes
functionally linked to ATP binding and hydrolysis, which are
required to drive the dimerization and dissociation of the NBDs
during the propagation of the transport cycle. Although the
MsbA-DK382 mutant can operate in a DpH-dependent manner
in the absence of ATP, the addition of ATP traps this mutant in
an ATP-bound state and renders it transport-inactive (Fig. 6e) in
an analogous manner as observed in ATP-containing cells
(Fig. 1c,d). This inhibitory trapping was mimicked by the addi-
tion of the non-hydrolysable AMP-PNP to MsbA-WT (Fig. 6a).
The inhibitory effect of AMP-PNP on DpH-dependent ethidium
accumulation in the proteoliposomes was not observed for
MsbA-MD lacking the NBD (Fig. 6f).
MsbA-WT is more efﬁcient than MsbA-MD. The observations
on active drug transport by MsbA-MD raise questions about the
functional importance of ATP binding and hydrolysis in full-
length MsbA. The direct comparison of the transport activities of
MsbA-WT and MsbA-MD in cells show that MsbA-WT catalyses
ethidium efﬂux to lower intracellular steady-state levels than
MsbA-MD (Fig. 1c,d). When cell growth was measured in the
presence of the MsbA substrate erythromycin15, MsbA protein
expression caused signiﬁcant shifts in the erythromycin
concentration at which the growth rate is half-maximal (IC50),
from 0.004 mM or the non-expressing control to 0.393 mM
(P¼ 0.008) for MsbA-WT and 0.094 mM (P¼ 0.003) for MsbA-
MD; the IC50 for MsbA-DK382 (0.051mM) was close to control
(Fig. 6g). Hence, the enhanced efﬁciency of efﬂux by full-length
MsbA compared with the NBD-less protein was also found in the
ability of the MsbA proteins to confer cellular resistance to the
antibiotic erythromycin. The ATP-dependent dimerization of
the NBDs with closure of the substrate-binding cavity towards the
inside surface of the membrane facilitates capture of substrate
from the cellular interior and/or inner membrane leaﬂet, and
enables efﬂux against a larger drug concentration gradient and/or
lipid–water partition coefﬁcient. The ATP dependence therefore
enhances the directionality of the transport reaction.
Discussion
Although MsbA is an ABC transporter that mediates substrate
transport in an ATP-dependent manner, the experiments in
intact cells and proteoliposomes prepared from E. coli phospho-
lipids demonstrate for the ﬁrst time that the ATP-binding-
associated power stroke during drug transport is assisted by
proton coupling via apparent drug–proton antiport. The dissipa-
tion of the DpH (interior alkaline) in cells by the addition of
nigericin blocks MsbA-WT-mediated ethidium efﬂux (Fig. 1f).
Conversely, the artiﬁcial imposition of the DpH (inside acidic) in
proteoliposomes initiates (i) the accumulation of ethidium and
chloramphenicol by puriﬁed, inside-out oriented MsbA-WT
above the equilibration level (Figs 4c and 5a,b) and (ii) proton
efﬂux in a chloramphenicol-dependent manner (Fig. 5c). The role
of the DpH in MsbA-mediated transport in cells is also supported
by the observations on the erythromycin efﬂux by MsbA-MD
against the inwardly directed drug concentration gradient that
impairs growth of the non-expressing control cells (Fig. 6g).
Proton-coupled ethidium efﬂux by MsbA-WT is inhibited by the
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Figure 3 | Schematic showing methods for artiﬁcial imposition of
electrochemical ion gradients in proteoliposomes. The Dc (interior
positive), DpH (interior acidic), Dp (interior positive and acidic), DcREV
(interior negative), DpDcREV (interior negative and acidic), or DpHREV
(interior alkaline) were imposed by 100-fold dilution of proteoliposomes
containing inside-out oriented MsbA-WTor MsbA-MD as described in the
main text. Inclusion of DNA in the lumen allows the recording of the
ﬂuorescence emission of accumulated ethidium.
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Dc (interior negative) in cells (Fig. 1f) and equivalent Dc
(interior positive) in the proteoliposomes (Fig. 4c). Together with
the observed stimulation of transport in proteoliposomes by the
DcREV (interior negative; Fig. 4e), the data point to apparent
electrogenic antiport of ethidiumþ and nHþ with no1. Thus,
two or more ethidiumþ molecules are exchanged per Hþ , which
is consistent with the presence in this type of ABC transporter of
two cavities at the MD–MD interface that are related by twofold
pseudosymmetry and that can be separated by mutation10,24,26,27.
Proton-coupled transport is associated with the MD of MsbA; the
observations on DpH dependence for MsbA-WT in intact cells
and proteoliposomes could all be reproduced using MsbA-MD
that lacks the NBD (Figs 1e and 4d).
Evidence was obtained that proton coupling operates in
conjunction with a functional catalytic cycle at the NBDs when
nucleotide is present. First, ethidium efﬂux in metabolically
active cells containing mM concentrations of ATP21 was inhibited
by the MsbA-DK382 mutation (Fig. 1c). As the NBDs are
conformationally coupled to the MDs, the reduced rate of ATP
hydrolysis in the mutant will cause more persistent binding
of the nucleotide, which in turn will block the propagation
of the catalytic cycle, and, hence, inhibit transport. Second, for
MsbA-WT this transport reaction in proteoliposomes was
signiﬁcantly inhibited by the inclusion of the non-hydrolysable
ATP analogue AMP-PNP in the external buffer (Fig. 6a). Third,
DpH (interior acidic)-dependent ethidium accumulation in
proteoliposomes by MsbA-DK382 was inhibited by the addition
of Mg-ATP to the external buffer where the NBDs reside
(Fig. 6e). Fourth, the addition of ATP or AMP-PNP had no effect
on DpH (interior acidic)-dependent ethidium accumulation in
proteoliposomes containing MsbA-MD without the NBD
(Fig. 6f). Finally, the imposition of a DpH stimulated the
MsbA-WT ATPase activity in proteoliposomes (Fig. 6b–d). The
dependence of drug transport on the genotype of the expressed or
reconstituted MsbA proteins demonstrates that the drug
transport activity is not dependent on auxiliary proteins but on
MsbA itself. This conclusion is consistent with the mass
spectrometry analysis demonstrating insigniﬁcant levels of
contaminating membrane transporters or NBDs in our protein
preparations (Fig. 2c).
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Figure 4 | Ethidium transport in proteoliposomes. (a–d) Ethidium transport in DNA-loaded empty liposomes (a) or proteoliposomes containing the
MsbA-DED triple mutant (b), MsbA-WT (c) or MsbA-MD (d) with imposed DpH (pHin 6.8/pHout 8.0), Dc (interior positive), proton-motive force
(Dp ¼ Dc ZDpH in which Z equalsB58mV at 20 C), DpHREV (pHin 8.0/pHout 6.8), or in the absence of ion gradients (pHin 6.8/pHout 6.8, termed No
gradient and pHin 8.0/pHout 8.0, No gradient 8/8). No gradient 8/8 for (a,b,d) was very close to the No gradient control, and is not shown for clarity of
presentation. The 5-fold accumulation of ethidium by MsbA-WT is indicated in the ﬂuorescence versus time graph in (c). (e,f) Effect of the imposition of a
reversed DcREV (interior negative) without or with the DpH (interior acidic) (DpDcREV ¼ DcREV ZDpH) on ethidium transport in proteoliposomes
containing MsbA-WT (e) or empty liposomes (f). Data represent observations in three or more independent experiments with independently prepared
batches of proteoliposomes. Values in histograms show signiﬁcance of ﬂuorescence levels at steady-state, and are expressed as mean±s.e.m. (one-way
analysis of variance; *Po0.05; **Po0.01; ***Po0.001; ****Po0.0001).
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Protons can have different roles in the mechanisms of
membrane transporters. A role of Hþ in primary-active
transport was previously described for the P-type Ca2þ -ATPase
(SERCA), in which protons neutralize Ca2þ -coordinating
carboxylates following substrate dissociation, essentially giving
primary-active transmembrane proton-Ca2þ antiport28,29. Hþ
binding and movement in proton-coupled secondary-active
transporters are also known to induce changes in electrostatic
and hydrogen-bonding interactions between interhelix side
chains that underlie the conformational transitions associated
with proton–substrate symport and antiport30,31. The ﬁnding of
proton-coupled transport by MsbA suggests that similar
mechanistic principles are relevant for ABC exporters. Indeed,
recent structural studies on the antibacterial peptide ABC
exporter McjD from E. coli conclude that the conformational
transitions required for substrate transport might not all be
dependent on ATP binding and hydrolysis32. The MsbA data
share similarities with observations on the dual mode of energy
coupling by the arsenite and antimonite-translocating ArsB
protein from E. coli33,34, which acts as a secondary-active
metalloid–proton antiporter, but when associated with the ArsA
ATPase subunit can utilize ATP for improved extrusion
efﬁciency. The ﬁndings for MsbA-MD are reminiscent to those
described for the MD of the ABC exporter LmrA from L. lactis,
which catalyses apparent ethidium–proton symport22,35,
illustrating that the coupled transport of substrate and protons
is more widespread among ABC exporters. Our conclusions
introduce proton coupling as a new parameter in the mechanism
of MsbA, and point to the existence of proton-coupled
conformational transitions in its transport cycle. This work is of
fundamental importance for our understanding of how ABC
exporters operate.
Methods
Bacterial strains and plasmids. The drug-hypersensitive L. lactis strain NZ9000
DlmrA DlmrCD strain devoid of the endogenous ABC multidrug transporters
LmrA and LmrCD36,37 was used as a host for expression vector pNZ8048-derived
plasmids36 that contain a chloramphenicol resistance marker gene, nisin-inducible
nisA promoter and His-tagged wild-type (WT) or mutant MsbA gene, or truncated
MsbA gene encoding the MD only.
Construction of MsbA mutants. To express N terminally His-tagged MsbA-MD,
the corresponding region of the msbA gene from E. coli was PCR-ampliﬁed from
pNZMsbA15 with the forward primer 50-GGAGGCACTCACCATGGGC-30 and
the reverse primer 50-CGGATAAGTTCTAGATTAATTGCGGAATTCCACGT
CGGC-30 to insert a TAA stop codon after the codon for N346, equivalent to H353
in previous work on LmrA22, followed by an XbaI site at the 30 end. NcoI and XbaI
(Roche Applied Science, Herts, UK) were used to digest the PCR product, which
was followed by ligation of the DNA fragment into the linearized vector pNZ8048
downstream of the nisA promoter, yielding pNZMsbA-MD. For the generation of
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pNZMsbA-DED (D41N E149Q D252N) the following primers were used: D41N
(forward) 50-GCCAGCAACACCTTCATGTTATCGCTCC-30, (reversed) 50-AAG
GTGTTGCTGGCTGCGTTGAGGATTA-30; E149Q (forward) 50-TGTGCGTCAA
GGTGCGTCGATCATCGGC-30, (reversed) 50-ACGCACCTTGACGCACAACAG
TAATCAG-30 ; D252N (forward) 50-CATCTCTAATCCGATCATTCAGCTG
ATC-30 , (reversed) 50-TGATCGGATTAGAGATGGAAGAGGCTGA-30 . The
DNA was sequenced to ensure that only the intended changes were introduced.
Growth conditions and protein expression. L. lactis NZ9000 DlmrA DlmrCD was
grown overnight in M17 medium (Difco) supplemented with 0.5% glucose and
5 mgml 1 chloramphenicol at 30 C to an OD660 of 0.5–0.6. For protein expres-
sion, cells harbouring pNZMsbA, pNZMsbA-MD, pNZMsbA-DK382 (ref. 16),
pNZMsbA-DED or pNZ8048 (empty vector) were incubated for 1 h at 30 C in the
presence of a 1:1,000 dilution of the culture supernatant of nisin-A producing
L. lactis strain NZ9700, corresponding to a nisin A concentration ofB10 pgml 1
(ref. 38), unless stated otherwise.
Ethidium transport in de-energized cells. L. lactis NZ9000 DlmrA DlmrCD cells
expressing MsbA, MsbA-DK382 or MsbA-MD and non-expressing control cells
were grown to an OD660 of 0.6, and protein expression was induced for 1 h at 30 C
by 10 pgml 1 nisin A. Cell pellets from 50ml culture were harvested by
centrifugation (6,500g for 10min at 4 C) and washed with ice-cold washing buffer
(50mM KPi, pH 7.0, containing 5mM MgSO4). To deplete intracellular ATP levels,
cells were incubated with 0.5mM of the protonophore 2,4-dinitrophenol for 30min
at 30 C. The protonophore was removed by centrifugation, followed by washing of
cells with the washing buffer. Finally, the cells were resuspended in washing buffer
to an OD660 of 5.0. For each measurement, cells were diluted at 1:10 into 2ml
washing buffer in a glass cuvette. Fluorescence was followed in a LS 55B
Luminescence Spectrometer (PerkinElmer, MA, USA) at excitation and emission
wavelengths of 500 and 580 nm with slit widths of 10 and 5 nm, respectively.
Owing to differences in the uptake rates, ATP-depleted control cells and cells
containing MsbA-WT or MsbA-MD were pre-loaded with 2 mM ethidium bromide
for 50, 25 and 30min, respectively, to a similar starting ﬂuorescence level.
Active efﬂux was subsequently initiated by the addition of 0.5% glucose, which
re-energized the cells and ﬂuorescence was followed for B10min. To further
determine the inﬂuence of the magnitude and composition of the Dp on
MsbA-mediated transport, ionophores nigericin and valinomycin were added (ﬁnal
concentration 1 and 0.1 mM, respectively) before activation of cells. When cells are
suspended in high Kþ containing buffer, nigericin mediates the antiport of Hþ
and Kþ down their concentration gradients, thereby selectively dissipating DpH in
an electroneutral manner. Furthermore, valinomycin mediates electrogenic uniport
of Kþ , allowing the electrophoretic uptake of Kþ in cells with dissipation of the
Dc (ref. 39).
Preparation of inside-out membrane vesicles. Inside-out membrane vesicles
were prepared from L. lactis NZ9000 DlmrA DlmrCD cells harbouring pNZ8048-
based expression vectors using cell disruption equipment15. For this purpose,
lactococcal cells were grown at 30 C to an OD660 of 0.6–0.8 and incubated for 1 h
in the presence of nisin A to induce protein expression. Cells were then harvested
by centrifugation at 13,000g, 12min, 4 C and washed with ice-cold 100mM KPi
(pH 7.0) or 100mM K-HEPES (pH 7.0) when the vesicles were prepared to measure
ATPase activity. The cell pellet was resuspended in 20mM KPi/K-HEPES
containing Complete-Protease Inhibitor Cocktail (Roche) followed by the addition
of 3mgml 1 lysozyme (from chicken egg white) and further incubation for 30min
at 30 C. Cell lysis was achieved by passage twice through a Basic Z 0.75 kW
Benchtop Cell Disruptor (Constant Systems, Northlands, UK) at 20 kpsi. The
suspension was supplemented with 10 mgml 1 DNase and 10mM MgSO4
andincubated for 30min at 30 C to remove DNA. Subsequently, 15mM K-EDTA
(pH 7.0) was added to prevent the aggregation of membrane vesicles. A low spin at
13,000g for 40min was performed to remove cell debris and whole cells. Membrane
vesicles were harvested from the supernatant by ultra-centrifugation at 125,000g for
1 h at 4 C. The membrane vesicles were resuspended in 50mM KPi/K-HEPES
(pH 7.0) containing 10% glycerol and stored as 500 ml aliquots in liquid nitrogen.
The expression of MsbA proteins in membrane vesicles was assessed on
Coomassie-stained SDS–PAGE, and immunoblots probed with primary mouse
anti-polyhistidine tag antibody (Sigma-Aldrich, cat. no.: H1029) and secondary
goat antimouse antibody (Sigma-Aldrich, cat. no.: A4416) were used at dilutions of
1:1,000 and 1:5,000, respectively (Supplementary Fig. 1).
Puriﬁcation of His-tagged MsbA proteins. His-tagged MsbA proteins were
puriﬁed from membrane vesicles by Ni2þ -nitrilotriacetic acid (NTA) afﬁnity
chromatography7,24,38. Membrane vesicles (diluted to 5mgml 1) were solubilized
in buffer containing 50mM KPi or K-HEPES (pH 8.0), 10% (v/v) glycerol, 0.1M
NaCl and 1% (w/v) n-dodecyl-b-D-maltoside (DDM) (Melford Laboratories Ltd.,
UK) for 4 h by gently mixing on a rotating wheel at 4 C. Insoluble particles were
removed by centrifuging the mixture at 125,000g, 4 C for 40min. The solubilized
protein was mixed with Ni2þ -NTA resin at a ratio of 10mg His-tagged protein per
ml of resin. The resin was pre-equilibrated by washing thrice with ﬁve resin
volumes of Milli Q water and twice with ﬁve resin volumes of wash Buffer A
(50mM KPi or K-HEPES (pH 8.0), 0.1M NaCl, 10% (v/v) glycerol, 0.05% (w/v)
DDM and 20mM imidazole). The suspension was left on a rotating wheel for
overnight binding at 4 C, after which the resin was collected by centrifugation
and transferred to a 2ml volume Biospin disposable chromatography column
(Bio-Rad). After subsequent washing with 20 volumes of wash Buffer A and 30
volumes of wash Buffer B (50mM KPi or K-HEPES (pH 7.0), 0.1M NaCl, 10% (v/v)
glycerol, 0.05% (w/v) DDM and 20mM imidazole added from 1M imidazole stock
(pH 8.0)), His-tagged protein was eluted with 3–4 volumes of Elution Buffer
(50mM KPi or K-HEPES (pH 7.0), 0.1M NaCl, 5% (v/v) glycerol, 0.05% (w/v)
DDM and 150mM imidazole added from 1M imidazole stock (pH 8.0)). The eluted
puriﬁed protein was kept on ice and was immediately used for experiments. Purity
of the protein was monitored on a 10% SDS–PAGE with Coomassie Brilliant Blue
staining.
LC–MS/MS mass spectrometry analysis. Puriﬁed MsbA proteins were reduced
(DTT) and alkylated (iodoacetamide) and subjected to enzymatic digestion with
trypsin overnight at 37 C. Aliquots were then pipetted into a sample vial and
loaded onto an autosampler for automated LC–MS/MS analysis40. All LC–MS/MS
experiments were performed using a nanoAcquity UPLC (Waters Corp., Milford,
MA) system and an LTQ Orbitrap Velos hybrid ion trap mass spectrometer
(Thermo Scientiﬁc, Waltham, MA). Separation of peptides was performed by
reverse-phase chromatography using a Waters reverse-phase nanocolumn (BEH
C18, 75 mm inner diameter 250mM, 1.7 mm particle size) at ﬂow rate of
300 nlmin 1. Peptides were initially loaded onto a pre-column (Waters UPLC
Trap Symmetry C18, 180 mm inner diameter 20mm, 5 mm particle size) from the
nanoAcquity sample manager with 0.1% formic acid for 5min at a ﬂow rate of
5 ml min 1. After this period, the column valve was switched to allow the elution of
peptides from the pre-column onto the analytical column. Solvent A was
waterþ 0.1% formic acid and solvent B was acetonitrileþ 0.1% formic acid. The
linear gradient employed was 5–40% B in 40min (total LC–MS/MS run time was
60min). The LC eluant was sprayed into the mass spectrometer by means of a New
Objective nanospray source. All m/z values of eluting ions were measured in the
Orbitrap Velos mass analyser, set at a resolution of 30,000. Data dependent scans
(Top 20) were employed to automatically isolate and generate fragment ions by
collision-induced dissociation in the linear ion trap, resulting in the generation of
MS/MS spectra. Ions with charge states of 2þ and above were selected for
fragmentation. Post run, the data were processed using Protein Discoverer (version
1.4., ThermoFisher). Brieﬂy, all MS/MS data were converted to mgf ﬁles and these
ﬁles were then submitted to the Mascot search algorithm (Matrix Science, London,
UK) and searched against the Uniprot L. lactis subsp. lactis strain IL1403 database
(taxon identiﬁer 1360) using a ﬁxed modiﬁcation of carbamidomethyl (C), variable
modiﬁcations of oxidation (M) and deamidation (NQ). The peptide mass tolerance
was set to 25 ppm, the fragment ion mass tolerance to 0.8 Da and the maximum
number of missed cleavages to 2.
Reconstitution of puriﬁed MsbA proteins. Puriﬁed protein (MsbA-WT,
MsbA-DK382, MsbA-DED or MsbA-MD) was reconstituted in proteoliposomes
prepared from acetone–ether-washed E. coli phospholipids7,38,41 diluted to
4mgml 1 in chloroform, which were mixed in a ratio of 3:1 (w/w) with egg-yolk
phosphatidylcholine (Avanti Polar Lipids Inc.). Solvent was evaporated using N2
gas after which the lipid mixture was rehydrated using Buffer 1 (10mM K-HEPES
(pH 6.8), 10mM Tris-Cl, 100mM K2SO4 and 100mM NH4SCN) or Buffer 2 (10mM
Tris-Cl (pH 8.0), 10mM K-HEPES and 100mM KSCN; see under ‘Substrate
transport in proteoliposomes’), and 1mgml 1 of sonicated calf thymus DNA
(Trevigen) for ethidium transport measurements. After resuspension, lipids were
extruded 11 times through a 400-nm polycarbonate ﬁlter to form unilamellar
liposomes of homogenous size and destabilized by the step-wise addition of Triton
X-100 which was followed at OD540 (ref. 38). For reconstitution, puriﬁed protein
was mixed with the detergent-destabilized liposomes in a 1/50 ratio (w/w) and
incubated at room temperature (RT) for 30min. Detergent was then removed using
polystyrene bio-beads (Bio-Bead SM-2, Bio-Rad). For this purpose, Bio-Beads were
pre-washed three times with methanol, once with ethanol and ﬁve times with water
before use. Successive extractions of detergent were achieved by incubating
proteoliposomes, ﬁrst with 80mgml 1 Bio-Beads for 2 h at RT, then with
8mgml 1 Bio-Beads for 2 h at 4 C and ﬁnally with 8mgml 1 Bio-Beads for 18 h
at 4 C. Proteoliposomes were harvested by centrifugation (130,000g for 30min,
4 C), resuspended in 3ml Buffer 1 or 2, in which the liposomes were prepared, and
incubated at 30 C for 20min with 10mM MgSO4 and 10mgml 1 DNase to
remove any DNA contamination from the lipid bilayer. Finally, liposomes were
harvested by centrifugation (130,000g for 30min, 4 C), resuspended in 150–200 ml
Buffer 1 or 2 that was used for their preparation and used immediately for
transport studies. Samples were maintained on ice.
Substrate transport in proteoliposomes. Ethidium transport measurements
with reconstituted proteoliposomes containing MsbA proteins were initiated by the
100-fold dilution of DNA-loaded proteoliposomes in 2ml of external buffer in a
3-ml ﬂuorescence cuvette (to a ﬁnal concentration of 20 mg membrane protein
per ml) to impose different electrochemical ion gradients. For this purpose,
proteoliposomes in Buffer 1 (see under ‘Reconstitution of puriﬁed MsbA proteins’)
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were diluted 100-fold in Buffer i (10mM K-HEPES (pH 8.0), 10mM Tris-Cl and
100mM K2SO4) to impose the Dp (interior positive and acidic), Buffer ii (10mM
K-HEPES (pH 8.0), 10mM Tris-Cl and 100mM KSCN) to impose the DpH (interior
acidic), or Buffer iii (10mM K-HEPES (pH 6.8), 10mM Tris-Cl, 50mM (NH4)2SO4
and 100mM K2SO4) to impose the Dc (interior positive). In experiments with the
DcREV, proteoliposomes in Buffer 2 (see under ‘Reconstitution of puriﬁed MsbA
proteins’) were diluted 100-fold into Buffer iv (10mM NMG-HEPES (pH 6.8),
10mM Tris-Cl and 50mM (NH4)2SO4) in the presence of 10 nmol per mg protein of
valinomycin to impose the DcREV (interior negative), Buffer v (10mM K-HEPES
(pH 8.0), 10mM Tris-Cl and 50mM K2SO4) to impose the DpH (interior acidic),
or Buffer vi (10mM NMG-HEPES (pH 8.0) and 10mM Tris-Cl) in the presence
10 nmol per mg protein valinomycin to impose the DpDcREV (interior negative
and acidic). After 30 s of recording, ethidium bromide (2 mM) was added and
ﬂuorescence was measured as a function of time in an LS 55B luminescence
spectrometer (Perkin-Elmer Life Sciences) with excitation and emission
wavelengths of 500 and 580 nm with slit widths of 10 and 5 nm, respectively.
In control experiments, proteoliposomes were diluted 100-fold in the buffer in
which they were prepared (pHin 6.8/pHout 6.8 and pHin 8.0/pHout 8.0) to measure
ethidium transport in the absence of ion gradients. In addition, empty liposomes
were prepared with nickel NTA elution buffer instead of puriﬁed protein, and these
were diluted in the same buffers as the proteoliposomes.
For measurements of DpH (interior acidic)-dependent chloramphenicol
transport, proteoliposomes were generated as described for ethidium transport,
but without DNA in the internal lumen, and diluted 100-fold (to 30 mg
phospholipid per ml) in 500 ml dilution buffer in glass tubes containing 2 mM
[3H]-chloramphenicol (3.33 TBqmol 1) (Sigma). At given time intervals, samples
were withdrawn, diluted with 2ml of ice-cold 0.1M lithium chloride, ﬁltered
immediately through cellulose nitrate ﬁlters (0.45 mm pore size) and washed once
with 2ml of the lithium chloride solution. Radioactivity retained on the ﬁlters was
measured by liquid scintillation counting. Transport data were corrected for
binding of chloramphenicol to the nitrocellulose ﬁlters. To provide evidence for
proton-coupled chloramphenicol transport by MsbA-WT, (proteo)liposomes were
prepared in Buffer 1 (interior acidic; pH 6.8) containing 100 mM of the pH
indicator BCECF (Molecular Probes). These (proteo)liposomes were diluted 100-
fold in Buffer ii (pH 8.0) to impose a Hþ gradient, or Buffer 1 for control
measurements in the absence of an ion gradient. BCECF ﬂuorescence was
measured with wavelengths for excitation at 502 nm and emission at 525 nm, and
with slit widths of 10 and 15 nm, respectively. Experiments were performed in
triplicate using independent batches of proteoliposomes.
ATPase activity in proteoliposomes. The ATPase activity of MsbA was
monitored in reconstituted proteoliposomes in the absence or presence of the
DpH, using the Malachite Green assay to measure the liberation of Pi over
time37,42. Proteoliposomes prepared in Buffer 1 were diluted 20-fold in Buffer ii as
described under ‘Substrate transport in proteoliposomes’ (Fig. 6b). To dissipate the
DpH, 1 mM nigericin was added immediately after dilution of proteoliposomes, and
the mixture was kept on ice for 5min before the measurements of ATPase activity.
The ATPase reaction was started by the addition of 2.5mM Mg-ATP (high grade
ATP from Sigma), after which Pi release was measured at 1 and 2min. Following
incubation at 30 C, the reactions were stopped by mixing 30-ml aliquots with
activated malachite green-ammonium molybdate for 5min in a 96-well plate.
Samples were subsequently incubated for 25min with 34% citric acid after which
the OD600 was determined. Pi release between t¼ 1min and t¼ 2min was
calculated. To conﬁrm that nigericin was able to dissipate the DpH, 100 mM BCECF
was added to the preparation Buffer 1 to include the probe in the lumen of the
proteoliposomes (Fig. 6c). BCECF ﬂuorescence emission was measured in a LS 55B
luminescence spectrometer with excitation and emission wavelengths of 535 and
590 nm with slit widths of 10 and 5 nm, respectively. For the experiments in Fig. 6d,
proteoliposomes prepared in buffer (pH 6.8 or 8.0) containing 10mM Tris-Cl and
10mM K-HEPES were diluted 20-fold in buffer (pH 8.0) containing 10mM Tris-Cl
and 10mM K-HEPES.
Orientation of MsbA in the membrane. Right-side-out membrane vesicles were
prepared by osmotic lysis of cells43. MsbA-WT expressing lactococcal cells from 1 l
culture were collected by centrifugation at 13,000g for 15min at 4 C. The pellet
was washed once in 100mM KPi (pH 7.0). Cells were resuspended in 5ml of the
same buffer containing half a tablet of complete protease inhibitor cocktail (Roche
Applied Science), 10mM MgSO4, 40mgml 1 lysozyme, and were incubated for
30min at 30 C under mild shaking. The protoplast suspension was mixed with
4.8ml of a 0.75M K2SO4, 10mgml 1 DNase and RNase while stirring, and
incubated for 2min at 30 C. The homogenized, concentrated protoplast
suspension was poured directly into 36ml 100mM KPi (pH 7.0). The lysate was
incubated for 20min at 30 C with vigorous swirling. K-EDTA, pH 7.0, was then
added to 20mM ﬁnal concentration, and the incubation was continued for 10min
at 30 C. Shortly after the addition of EDTA, the turbidity of the suspension
decreased and the viscosity increased. Finally, MgSO4 was added to a ﬁnal
concentration of 15mM and the incubation was continued for another 15min at
30 C; during this period the viscosity decreased. The lysates were centrifuged at
48,200g for 30min at 4 C. The pellet was resuspended in 48ml 50mM KPi buffer,
pH 7.0, containing 10mM MgSO4. The sample was centrifuged at 750g for 60min
at 4 C and the yellowish, milky, supernatant ﬂuid was carefully decanted and
centrifuged at 48,200g for 30min at 4 C. The high speed pellet obtained as
described above was resuspended by homogenization in 1ml 50mM KPi buffer
(pH 7.0) containing 10% glycerol and frozen in small aliquots of 100 ml and stored
in liquid nitrogen.
The orientation of MsbA proteins in right-side-out membrane vesicles,
inside-out membrane vesicles or proteoliposomes was assessed by determining the
accessibility of the N-terminal His-tag to digestion by protease K in the external
buffer41. Membrane proteins were diluted in 50mM K-HEPES (pH 7.0)
supplemented with 1mM CaCl2. The digestion was initiated by addition of
proteinase K at an enzyme-membrane protein ratio of 1:25 (w/w). The samples
were subsequently incubated at 0 C for 10min. The reaction was terminated by
the addition of 10mM phenylmethanesulphonyl ﬂuoride (from stock in ethanol),
after which 3 SDS–PAGE sample-loading buffer and 1mM DTT were added.
The samples were incubated at RT for 10min and analysed on immunoblot as
described under ‘Preparation of inside-out membrane vesicles’.
Cytotoxicity assays. L. lactis expressing MsbA-WT, MsbA-MD or MsbA-DK382,
and non-expressing control cells were grown as described under ‘Growth
conditions and protein expression’ at 30 C in 96-well plates in the presence of a
range of erythromycin concentrations. Nisin A was added at a concentration of
5 pgml 1 to induce protein expression, and growth was monitored by measuring
OD660 in a Versamax plate reader (Molecular Devices Wokingham, UK) at 30 C.
The maximum speciﬁc growth rate (mm) was determined from the change in OD660
over time, by ﬁtting the data to Nt ¼ N0emmt in which Nt and N0 are the cell
densities at times t and 0 h, respectively. The mm of the cells grown in the absence of
drug was set at 100% to calculate relative growth rates (Fig. 6g).
Statistical analyses. Signiﬁcance of data obtained with whole cells and
proteoliposomes was tested by one-way analysis of variance. Differences in
proteinase-K and ATPase results were assessed using the unpaired student-t test.
Asterisks directly above bars in the histograms refer to comparisons with control;
asterisks above lines refer to speciﬁc comparisons: *Po0.05; **Po0.01;
***Po0.001; ****Po0.0001.
Data availability. Data that support the ﬁndings of this study have been
deposited in the University of Cambridge data repository with the accession code
1810/255838 (https://www.repository.cam.ac.uk/handle/1810/255838) or available
from the corresponding author upon reasonable request.
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